You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 3, MARCH 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  SPECIAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Problems in the Conduct and Analysis of Randomized Clinical Trials

Are We Getting the Right Answers to the Wrong Questions?

Linda Rabeneck, MD; Catherine M. Viscoli, PhD; Ralph I. Horwitz, MD

Arch Intern Med. 1992;152(3):507-512.


Abstract

To achieve the goal of validity, the randomized clinical trial has emerged as the scientific "gold standard" for evaluating therapies in clinical medicine. Regardless of how well randomized clinical trials are designed, however, problems often occur during the conduct of the trials that give rise to methodologic challenges in the analysis of results. Primarily two types of problems, changes in intended treatment and the failure to ascertain the study outcomes, occur during the conduct of randomized clinical trials. We studied the current analytic strategies that are used to deal with these problems and how the use of these analytic strategies can change the focus of the research so that the trial no longer answers the relevant question. To ensure that the right question is answered, new methods of design and analysis are required that balance the goals of validity and clinical pertinence.

(Arch Intern Med. 1992;152:507-512)



Author Affiliations

From the Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn. Dr Rabeneck is now with Baylor College of Medicine, Houston (Tex) Veterans Affairs Medical Center.


Footnotes

Accepted for publication August 27, 1991.

Reprint requests to Yale University School of Medicine, Room IE-61 SHM, PO Box 3333, New Haven, CT 06510 (Dr Horwitz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Impact of packaged interventions on neonatal health: a review of the evidence
Haws et al.
Health Policy Plan 2007;22:193-215.
ABSTRACT | FULL TEXT  

Community-Based Interventions for Improving Perinatal and Neonatal Health Outcomes in Developing Countries: A Review of the Evidence
Bhutta et al.
Pediatrics 2005;115:519-617.
ABSTRACT | FULL TEXT  

Developing and Implementing Computerized Protocols for Standardization of Clinical Decisions
Morris
ANN INTERN MED 2000;132:373-383.
ABSTRACT | FULL TEXT  

Manual-Guided Psychosocial Treatment: A New Virtual Requirement for Pharmacotherapy Trials?
Carroll
Arch Gen Psychiatry 1997;54:923-928.
ABSTRACT  

Ethical Considerations in Clinical Neuroscience: Current Concepts in Neuroclinical Trials
Alves and Macciocchi
Stroke 1996;27:1903-1909.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.